The facilities will be built in West Columbia’s Saxe-Gotha Industrial Park, according to a July 9 news release from the drugmaker. Its construction of a large-scale vaccination manufacturing facility suggests it could soon partner with other pharma companies developing COVID-19 vaccine candidates.
Nephron, one of the country’s fastest-growing drugmakers, manufactures generic drugs, many of which treat respiratory problems that can arise from COVID-19.
More articles on pharmacy:
CVS Health launches campaign to encourage primary care during pandemic
Teva to serve as defendant in bellwether trial alleging generic drug price-fixing
Dozens of patents protect AbbVie’s pricey cancer drug against competition, report finds
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
